ArticleCancers2023

Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Antonella Turla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.